Prescribers must follow the relevant local and national guidance when treating an infection. Some anti-infectives require approval from the local Trust microbiology team for use, consult local guidance for further information.Not all anti-infectives listed in this chapter will be available in all localities; availability will be guided by local need and resistance patterns. |
Co-trimoxazole |
Formulary
|
Tablets 80mg/400mg, 160mg/800mg Low dose prophylaxis of pneumocystis jirovecii (Pneumocystis carinii) infections post-transplant. Subacute bacterial peritonitis prophylaxis. On advice of Microbiology only. **RAGs under consultation and awaiting update - Please use local/national antimicrobial guidelines to support prescribing choices. ** |
LSCMMG: Co-trimoxazole AMBER0 LSCMMG: Co-trimoxazole RED |
|